Skip to main content

Table 1 Details of patients recruited for study

From: Aggrecan heterogeneity in articular cartilage from patients with osteoarthritis

Patient ID Age Gender Condition Duration (yrs)a
1 73 F OA 12
2 69 F OA 15
3 74 M OA 2
4 71 F OA 3
5 68 F OA 4
6 61 F OA 1
7 72 F OA 3
8 75 F OA 8
9 66 F OA 1.5
10 59 F OA 5
11 51 M Post-traumatic OA 6
12 89 M OA 4
13 78 M OA 1
14 57 F AVN, secondary OA 8
15 73 F OA 3
16 59 M OA 6
17 87 F OA 1.5
18 89 F OA 7
19 77 M OA 1.5
20 77 F OA 4
21 78 M OA 5
22 71 F OA 3
23 71 M OA 1.5
24 46 F AVN, secondary OA 4
25 50 F RA 5.5
26 74 M OA 1.5
27 69 M OA 25
28 83 F OA 3
29 89 F OA 11
30 72 F OA second knee 13
31 80 F OA 20
32 77 M OA 5
33 71 F OA 11
34 95 F OA 3
  1. OA osteoarthritis, RA rheumatoid arthritis, AVN avascular necrosis
  2. aDuration is the time in years between first report of disease symptoms and surgery, for each patient